These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 9519882

  • 1. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
    Braspenning J, Marchini A, Albarani V, Levy L, Ciccolini F, Cremonesi C, Ralston R, Gissmann L, Tommasino M.
    Oncogene; 1998 Feb 26; 16(8):1085-9. PubMed ID: 9519882
    [Abstract] [Full Text] [Related]

  • 2. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
    Yamashita T, Segawa K, Fujinaga Y, Nishikawa T, Fujinaga K.
    Oncogene; 1993 Sep 26; 8(9):2433-41. PubMed ID: 8395681
    [Abstract] [Full Text] [Related]

  • 3. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
    Brokaw JL, Yee CL, Münger K.
    Virology; 1994 Dec 26; 205(2):603-7. PubMed ID: 7975265
    [Abstract] [Full Text] [Related]

  • 4. Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.
    Alunni-Fabbroni M, Littlewood T, Deleu L, Caldeira S, Giarrè M, Dell' Orco M, Tommasino M.
    Oncogene; 2000 May 04; 19(19):2277-85. PubMed ID: 10822378
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of transformation by the human papillomaviruses.
    Howley PM, Münger K, Werness BA, Phelps WC, Schlegel R.
    Princess Takamatsu Symp; 1989 May 04; 20():199-206. PubMed ID: 2562182
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
    Ledl A, Schmidt D, Müller S.
    Oncogene; 2005 May 26; 24(23):3810-8. PubMed ID: 15806172
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.
    Berezutskaya E, Yu B, Morozov A, Raychaudhuri P, Bagchi S.
    Cell Growth Differ; 1997 Dec 26; 8(12):1277-86. PubMed ID: 9419416
    [Abstract] [Full Text] [Related]

  • 15. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein.
    Zwerschke W, Joswig S, Jansen-Dürr P.
    Oncogene; 1996 Jan 04; 12(1):213-20. PubMed ID: 8552395
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7.
    Zerfass K, Levy LM, Cremonesi C, Ciccolini F, Jansen-Dürr P, Crawford L, Ralston R, Tommasino M.
    J Gen Virol; 1995 Jul 04; 76 ( Pt 7)():1815-20. PubMed ID: 9049387
    [Abstract] [Full Text] [Related]

  • 20. The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity.
    Wong HK, Ziff EB.
    J Virol; 1996 Jan 04; 70(1):332-40. PubMed ID: 8523545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.